Qrono Awarded Phase II SBIR Contract from the National Cancer Institute to Advance Novel Targeted Loco-Regional Chemotherapy Delivery Platform (QARRUS™)

The National Cancer Institute has awarded Qrono with a $1.M contract to advance development of Qrono’s QARRUS™ platform.

Read the full release on the Qrono website

Innovation Works